Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.52 |
| ▸ | GRIA4 | P48058 | 12/20 | 0.49 |
| ▸ | GRIA2 | P42262 | 7/20 | 0.49 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | NRP1 | O14786 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23629590 | 0.93 | KIF11 (0.52) | KIF11GRIA4GRIA2GRM2KDM4E | |
| SCHEMBL23957349 | 0.90 | KIF11 (0.49) | KIF11GRIA4GRIA2GRM2KDM4E | |
| SCHEMBL21950272 | 0.81 | KIF11 (0.47) | KIF11GRIA4GRIA2GRM2KDM4E | |
| SCHEMBL12762364 | 0.78 | KIF11 (0.46) | KIF11GRIA4GRIA2KDM4EMAPT | |
| SCHEMBL17711075 | 0.76 | KIF11 (0.53) | KIF11GRIA4GRIA2KDM4EMAPT | |
| SCHEMBL23957261 | 0.75 | KDM4E (0.45) | GRIA4GRIA2KDM4ENPSR1MAPT | |
| SCHEMBL22036556 | 0.75 | KIF11 (0.35) | KIF11GRIA4GRIA2KDM4EMAPT | |
| SCHEMBL23957342 | 0.75 | PTPN1 (0.50) | GRIA4GRIA2KDM4ENPSR1MAPT | |
| SCHEMBL21913681 | 0.75 | HSD17B10 (0.47) | GRIA4GRIA2KDM4EMAPTDHODH | |
| SCHEMBL30662436 | 0.74 | KIF11 (0.50) | KIF11GRIA4GRIA2KDM4ENPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | INTS9, GTF2I, BRI3BP | KIF11 3031/4885GRIA4 665/4885GRIA2 1687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.